Oracles of Eye Innovation Podcast
Oracles of Eye Innovation Podcast
Podcast Description
Oracles of Eye Innovation explores the journeys of entrepreneurs shaping the future of eye care. A mash-up of Medevise’s Business of Eye Innovation Podcast and the Oracles of Eye Innovation webinar series, this podcast highlights the real stories behind ophthalmic innovation. From those who always knew that this was their path to the accidental entrepreneurs who find themselves following a path that they never expected, each episode reveals what it takes to turn vision into reality.
Podcast Insights
Content Themes
The podcast focuses on the journeys of entrepreneurs in ophthalmic innovation, covering topics such as technological advancements in cataract surgery, the impact of AI on eye care, and unexpected paths to entrepreneurship with specific episodes like a deep dive into robotic innovation in cataract surgery led by Dr. Jean-Pierre Hubschman, showcasing both emotional and practical aspects of developing new solutions in eye health.
Oracles of Eye Innovation explores the journeys of entrepreneurs shaping the future of eye care. A mash-up of Medevise’s Business of Eye Innovation Podcast and the Oracles of Eye Innovation webinar series, this podcast highlights the real stories behind ophthalmic innovation. From those who always knew that this was their path to the accidental entrepreneurs who find themselves following a path that they never expected, each episode reveals what it takes to turn vision into reality.
In this episode of Oracles of Eye Innovation, Kris Morrill speaks with Michael O’Rourke, CEO of Re-Vana, about the company’s groundbreaking sustained-release drug delivery platforms that aim to dramatically reduce the global burden of intravitreal injections. Michael shares insights from his career in ophthalmic innovation and how a passionate team is driving the company from academic roots to an emerging biotech leader. Together, they explore the urgent need for new solutions in retinal care and how sustained-release technologies may reshape treatment for millions of patients worldwide.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.